HCPLive Network

Hyperbaric Oxygen Shows No Benefit for Diabetic Foot Ulcers

THURSDAY, Feb. 28 (HealthDay News) -- For patients with diabetic foot ulcers, use of hyperbaric oxygen (HBO) is not associated with improved healing or with a decrease in the likelihood of amputation, according to a study published online Feb. 19 in Diabetes Care.

David J. Margolis, MD, PhD, from the University of Pennsylvania, in Philadelphia, and colleagues compared the effectiveness of HBO with other conventional therapies in a longitudinal observational cohort study including 6,259 individuals with diabetes, adequate lower limb arterial perfusion, and foot ulcers extending through the dermis.

In propensity score-adjusted models, the researchers found that individuals receiving HBO were significantly less likely to have healing of their foot ulcer (hazard ratio, 0.68) and significantly more likely to have an amputation (hazard ratio, 2.37). HBO was not found to improve the likelihood of wound healing or to reduce the likelihood of amputation in additional analyses including use of an instrumental variable to ascertain the robustness of the results to unmeasured confounding.

"In conclusion, HBO did not appear to be useful for the prevention of amputation and did not improve the likelihood that a wound would heal in a cohort of patients defined by Centers for Medicare and Medicaid Services eligibility criteria," write the authors.

Two authors disclosed financial ties to the National Healing Corp. One of the authors is a consultant to Healogics, which fully owns the National Healing Corporation.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
A support group developed by a hospital in New York has shown that patients with rheumatoid arthritis can see their condition improve by not only addressing the physical symptoms but the psychological issues as well.
A Texas infant has died from Legionnaires' disease after being born in a whirlpool tub. The report of the infant's death appears in the January 2015 issue of the US Centers for Disease Control and Prevention's Emerging Infectious Diseases.
A screening test has identified more than 50 U.S. Food and Drug Administration-approved medications that could be helpful in treating people with Ebola, researchers report. The study was published online Dec. 17 in Emerging Microbes and Infections.
More Reading